Henrique Veiga-Fernandes, PhD

Henrique Veiga-Fernandes studied Veterinary Medicine at University of Lisbon, Portugal and at Università degli Studidi Milano, Italy. In 2002, he obtained a PhD in Immunology from Université René Descartes, Paris, France, before moving to the National Institute for Medical Research, London, UK, as a postdoc. In 2009, he set up his independent research group at the Institute of Molecular Medicine, Portugal, and he served as member of the direction team from 2014 to 2016. In that year, Henrique Veiga-Fernandes joined the Champalimaud Centre for the Unknown, Portugal, where he is currently a Group Leader and Research Director. Henrique Veiga-Fernandes made foundational discoveries in the areas of adaptive and innate immunity, more recently pioneering the area of peripheral neuro-immune interactions. Henrique Veiga-Fernandes integrates the Board of Reviewing Editors of Science AAAS, USA, he was elected a member of the European Molecular Biology Organisation (EMBO) in 2015, and he was made Commander of the Order of Sant’Iago da Espada by Portugal in the same year. He integrated the EMBO Young Investigator Programme in 2008 and he secured several European Research Council (ERC) awards (2007, 2013, 2015, 2017 and 2023). He won the Pfizer Prize for basic Science (2014, 2016, 2020 and 2022), the senior research award from the Crohn’s and Colitis Foundation of America, USA (2014), the Innovator and Breakthrough Awards from the Kenneth Rainin Foundation, USA (2013 and 2014), the Allen Distinguished Investigator award in 2018, and the Chan Zuckerberg Initiative (CZI) Award, USA in 2020.